Mitotic Control in Mammalian Cells, Positive and Negative Regulation by Protein Phosphorylation

Author(s):  
Anne Fernandez ◽  
Ned Lamb
1991 ◽  
Vol 260 (2) ◽  
pp. L105-L112 ◽  
Author(s):  
A. K. Wilson ◽  
A. Takai ◽  
J. C. Ruegg ◽  
P. de Lanerolle

Cellular locomotion results from a series of spatially and temporally integrated reactions. The coordinated regulation of these reactions requires sensitive intracellular signaling mechanisms. Because protein phosphorylation reactions represent important signaling mechanisms in mammalian cells, we investigated the effect of okadaic acid, a phosphoprotein phosphatase inhibitor, on protein phosphorylation and macrophage motility. Okadaic acid was applied to rat alveolar macrophages, and motility was quantitated by a directed chemotaxis assay. Okadaic acid inhibits macrophage motility in a dose-dependent fashion; the concentrations for 50 and 100% inhibition were 3 and 25 microM, respectively. Protein phosphorylation studies demonstrated a 2.5-fold increase in total protein phosphorylation in macrophages treated with 25 microM okadaic acid. These experiments also demonstrated a dose-dependent increase in the phosphorylation of the 20-kDa light chain of myosin. Moreover, 25 microM okadaic acid 1) maximally increased myosin light chain phosphorylation by 6.6-fold, 2) raised the level of myosin associated with the cytoskeleton from a basal level of 47.0 to 96.7% of the total myosin, and 3) induced profound morphological changes as visualized by scanning electron microscopy. These data correlate an increase in protein phosphorylation with a decrease in macrophage motility. Furthermore, they suggest that phosphoprotein phosphatase inhibition may prevent motility by uncoupling coordinated processes, such as cytoskeletal reorganization, that are essential for macrophage motility.


2018 ◽  
Vol 25 (9) ◽  
pp. 1067-1074.e5 ◽  
Author(s):  
Václav Beránek ◽  
Christopher D. Reinkemeier ◽  
Michael S. Zhang ◽  
Alexandria D. Liang ◽  
Gene Kym ◽  
...  

1991 ◽  
Vol 56 (0) ◽  
pp. 417-425 ◽  
Author(s):  
R.T. Schimke ◽  
A.L. Kung ◽  
D.F. Rush ◽  
S.W. Sherwood

2004 ◽  
Vol 323 (3) ◽  
pp. 831-837 ◽  
Author(s):  
Andrey Nikiforov ◽  
Maria Svetlova ◽  
Lioudmila Solovjeva ◽  
Lioudmila Sasina ◽  
Joseph Siino ◽  
...  

2020 ◽  
Vol 64 (10-11-12) ◽  
pp. 495-498
Author(s):  
Alex Sobko

In a previous study, we characterized Dictyostelium SUMO targeted ubiquitin ligase (StUbL) MIP1 that associates with protein kinase MEK1 and targets SUMOylated MEK1 to ubiquitination (Sobko et al., 2002). These modifications happen in response to activation of MEK1 by the chemoattractant cAMP. Second site genetic suppressor of mek1- null phenotype (SMEK) was also identified in Dictyostelium. MEK1 and SMEK belong to the same linear pathway, in which MEK1 negatively regulates SMEK, which then negatively regulates chemotaxis and aggregation. RNF4 is mammalian homologue of MIP. RNF4 interacts with hSMEK2, the human homologue of Dictyostelium SMEK. We propose the existence of an evolutionarily conserved MEK1-SMEK signaling complex that upon MEK1 activation and SUMOylation, recruits ubiqutin ligase MIP1/RNF4, which, in turn, ubiquitinates SMEK and targets this protein for proteasomal degradation. This could be a mechanism for negative regulation of SMEK by MEK1 signaling.


2001 ◽  
pp. 145-162
Author(s):  
Barbara Di Fiore ◽  
Giulia Guarguaglini ◽  
Patrizia Lavia

Author(s):  
Ramesh C. Adlakha ◽  
Chintaman G. Sahasrabuddhe ◽  
David A. Wright ◽  
Hélène Bigo ◽  
Potu N. Rao

2018 ◽  
Vol 28 (23) ◽  
pp. 3824-3832.e6 ◽  
Author(s):  
Scott Rata ◽  
Maria F. Suarez Peredo Rodriguez ◽  
Stephy Joseph ◽  
Nisha Peter ◽  
Fabio Echegaray Iturra ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document